Neurology · Washington, DC
NPI
1063460251
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1327 18 Th Street NW
Washington, DC, 20036
Phone (202) 785-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
2,338 services
Medicare patients, 2024
211
Average age 76
Drug cost, 2024
$234K
1,358 prescriptions
Company payments, 2025
$1,752
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pedro S Buarque de Macedo was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 965 times for 176 patients. In total Pedro S Buarque de Macedo billed 2,338 services in 28 codes, and Medicare paid $215K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 965 | 176 | $24.93 | $24K |
| 99215 Office E&M - Established | Office | 909 | 175 | $141.62 | $129K |
| 99214 Office E&M - Established | Office | 233 | 46 | $105.19 | $25K |
| 99205 Office E&M - New | Office | 96 | 96 | $172.11 | $17K |
| 96132 Behavioral Health Services | Office | 17 | 17 | $100.69 | $1,712 |
| 95938 Electrical Nerve Conductivity | Office | 13 | 13 | $330.15 | $4,292 |
| 99483 Office/Outpatient Services | Office | 13 | 11 | $220.05 | $2,861 |
By year: 2022 $126K for 1,011 services; 2023 $153K for 1,652 services; 2024 $215K for 2,338 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 12 | $2.96 | $47.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Pedro S Buarque de Macedo prescribed most often to Medicare patients was Rivastigmine, with 79 prescriptions and refills. In total Pedro S Buarque de Macedo wrote 1,358 Medicare prescriptions that cost $234K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rivastigmine Generic | 79 | 87 | 17 | $13K |
| Clonazepam Generic | 78 | 86 | 19 | $212 |
| Mirtazapine Generic | 63 | 81 | 16 | $1,342 |
| Fluoxetine Hcl Generic | 54 | 104 | 11 | $1,078 |
| Lamotrigine Er Lamotrigine | 54 | 74 | 11 | $6,096 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 48 | 80 | 15 | $1,976 |
| Olanzapine Generic | 46 | 63 | Under 11 | $975 |
| Trintellix Vortioxetine Hydrobromide | 44 | 76 | 11 | $36K |
| Bupropion Xl Bupropion Hcl | 40 | 58 | Under 11 | $727 |
| Diazepam Generic | 33 | 33 | 15 | $264 |
| Lorazepam Generic | 31 | 31 | Under 11 | $116 |
| Lithium Carbonate Er Lithium Carbonate | 28 | 36 | Under 11 | $277 |
| Topiramate Generic | 24 | 33 | Under 11 | $122 |
| Alprazolam Generic | 22 | 22 | 12 | $107 |
| Quetiapine Fumarate Generic | 22 | 26 | Under 11 | $531 |
Brand drugs: 146 claims; generic drugs: 1,212 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pedro S Buarque de Macedo $1,752 ($1,752 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $312.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $312 |
| Eisai Inc. 4523.T | 15 | $296 |
| Lilly USA, LLC LLY | 10 | $275 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 8 | $171 |
| Argenx US, Inc. ARGX | 5 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $120 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $95.87 |
| Life Molecular Imaging Ltd | 1 | $45.02 |
| Genentech USA, Inc. ROG.SW | 1 | $31.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.